PLEASE SCROLL TO THE BOTTOM OF THIS PAGE AND CLICK "TAKE COURSE" TO PROCEED TO THE EVALUATION AND OBTAIN YOUR CERTIFICATE

 

Recognize why physicians believed that SGLT2 inhibitors might be effective for the treatment of chronic heart failure.
Discuss whether the action of SGLT2 inhibitors to lower glucose was related to their effects on the heart and kidneys.
Describe the new evidence that SGLT2 inhibitors are effective in patients with chronic heart failure, with or without diabetes.
 
Session date: 
03/17/2021 - 12:00pm to 1:00pm CDT
Location: 
Virtual: WebEx
Dallas, TX
United States
  • 1.00 AMA PRA Category 1 Credit
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance
Please login or register for this course.